Literature DB >> 22682923

DNA cleavage induced by antitumor antibiotic leinamycin and its biological consequences.

Velliyur Viswesh1, Allison M Hays, Kent Gates, Daekyu Sun.   

Abstract

The natural product leinamycin has been found to produce abasic sites in duplex DNA through the hydrolysis of the glycosidic bond of guanine residues modified by this drug. In the present study, using a synthetic oligonucleotide duplex, we demonstrate spontaneous DNA strand cleavage at leinamycin-induced abasic sites through a β-elimination reaction. However, methoxyamine modification of leinamycin-induced abasic sites was found to be refractory to the spontaneous β-elimination reaction. Furthermore, this complex was even resistant to the δ-elimination reaction with hot piperidine treatment. Bleomycin and methyl methanesulfonate also induced strand cleavage in a synthetic oligonucleotide duplex even without thermal treatment. However, methoxyamine has a negligible effect on DNA strand cleavage induced by both drugs, suggesting that the mechanism of DNA cleavage induced by leinamycin might be different from those induced by bleomycin or methyl methanesulfonate. In this study, we also assessed the cytotoxicity of leinamycin against a collection of mammalian cell lines defective in various repair pathways. The mammalian cell line defective in the nucleotide excision repair (NER) or base excision repair (BER) pathways was about 3 to 5 times more sensitive to leinamycin as compared to the parental cell line. In contrast, the radiosensitive mutant xrs-5 cell line deficient in V(D)J recombination showed similar sensitivity towards leinamycin compared to the parental cell line. Collectively, our findings suggest that both NER and BER pathways play an important role in the repair of DNA damage caused by leinamycin.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682923      PMCID: PMC3389147          DOI: 10.1016/j.bmc.2012.05.033

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  42 in total

1.  Chemical properties of the leinamycin-guanine adduct in DNA.

Authors:  Tony Nooner; Sanjay Dutta; Kent S Gates
Journal:  Chem Res Toxicol       Date:  2004-07       Impact factor: 3.739

Review 2.  Biologically relevant chemical reactions of N7-alkylguanine residues in DNA.

Authors:  Kent S Gates; Tony Nooner; Sanjay Dutta
Journal:  Chem Res Toxicol       Date:  2004-07       Impact factor: 3.739

3.  A fluorimetric assay for the spontaneous release of an N7-alkylguanine residue from duplex DNA.

Authors:  Ekaterina Shipova; Kent S Gates
Journal:  Bioorg Med Chem Lett       Date:  2005-04-15       Impact factor: 2.823

4.  Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.

Authors:  Melissa L Fishel; Ying He; Martin L Smith; Mark R Kelley
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

5.  Rate of depurination of native deoxyribonucleic acid.

Authors:  T Lindahl; B Nyberg
Journal:  Biochemistry       Date:  1972-09-12       Impact factor: 3.162

6.  Small molecules that mimic the thiol-triggered alkylating properties seen in the natural product leinamycin.

Authors:  Tonika Chatterji; Murat Kizil; Kripa Keerthi; Goutam Chowdhury; Tomás Pospísil; Kent S Gates
Journal:  J Am Chem Soc       Date:  2003-04-30       Impact factor: 15.419

7.  A new approach to the study of the base-excision repair pathway using methoxyamine.

Authors:  M Liuzzi; M Talpaert-Borlé
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

8.  Sequence specificity of DNA alkylation by the antitumor natural product leinamycin.

Authors:  Hong Zang; Kent S Gates
Journal:  Chem Res Toxicol       Date:  2003-12       Impact factor: 3.739

9.  Cellular response and molecular mechanism of antitumor activity by leinamycin in MiaPaCa human pancreatic cancer cells.

Authors:  Stephen Bassett; Rheanna Urrabaz; Daekyu Sun
Journal:  Anticancer Drugs       Date:  2004-08       Impact factor: 2.248

10.  Synthesis and antitumor activity of novel C-8 ester derivatives of leinamycin.

Authors:  Yutaka Kanda; Tadashi Ashizawa; Kenji Kawashima; Shun-ichi Ikeda; Tatsuya Tamaoki
Journal:  Bioorg Med Chem Lett       Date:  2003-02-10       Impact factor: 2.823

View more
  3 in total

1.  Synthesis and evaluation of 8,4'-dideshydroxy-leinamycin revealing new insights into the structure-activity relationship of the anticancer natural product leinamycin.

Authors:  Tao Liu; Ming Ma; Hui-Ming Ge; Chunying Yang; John Cleveland; Ben Shen
Journal:  Bioorg Med Chem Lett       Date:  2015-05-30       Impact factor: 2.823

2.  Leinamycin E1 acting as an anticancer prodrug activated by reactive oxygen species.

Authors:  Sheng-Xiong Huang; Bong-Sik Yun; Ming Ma; Hirak S Basu; Dawn R Church; Gudrun Ingenhorst; Yong Huang; Dong Yang; Jeremy R Lohman; Gong-Li Tang; Jianhua Ju; Tao Liu; George Wilding; Ben Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

3.  P450-Catalyzed Tailoring Steps in Leinamycin Biosynthesis Featuring Regio- and Stereoselective Hydroxylations and Substrate Promiscuities.

Authors:  Thomas Kwong; Ming Ma; Guohui Pan; Dong Yang; Chunying Yang; Jeremy R Lohman; Jeffrey D Rudolf; John L Cleveland; Ben Shen
Journal:  Biochemistry       Date:  2018-08-02       Impact factor: 3.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.